Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer

Giandomenico Roviello; Roberto Petrioli; Edoardo Francini

doi:10.5301/jbm.5000019

$Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer$

Letter/Communication

Open access

Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer

Giandomenico Roviello, Roberto Petrioli and Edoardo Francini

The International journal of biological markers, Vol.28(3), pp.326-328

07/01/2013

DOI: 10.5301/jbm.5000019

PMID: 23592004

Files and links (1)

url

https://doi.org/10.5301/jbm.5000019View

Published (Version of record) Open Access

Abstract

Oncology

Biotechnology & Applied Microbiology

Life Sciences & Biomedicine

Science & Technology

Details

Title: Subtitle: Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer
Creators: Giandomenico Roviello - University of Siena
Roberto Petrioli - University of Siena
Edoardo Francini - University of Siena
Resource Type: Letter/Communication
Publication Details: The International journal of biological markers, Vol.28(3), pp.326-328
DOI: 10.5301/jbm.5000019
PMID: 23592004
ISSN: 0393-6155
eISSN: 1724-6008
Publisher: WICHTIG EDITORE
Number of pages: 3
Language: English
Date published: 07/01/2013
Academic Unit: Internal Medicine
Record Identifier: 9985221246302771

Metrics

1 Record Views

4 Times Cited - Web of Science